HOME THERAPY AREAS Extended Release Calcifediol (ERC) in Secondary Hyperparathyroidism (SHPT): A new option that challenges the current therapeutic approach. From studies to your clinical practice. 4 May 2023 Nephrology and Rare Diseases CKD-MBD and SHPT This video is a presentation of scientific data coupled with an interview between two Swiss nephrologists speakers: Dr. James Tataw, Moutier (Moderator & Speaker) Dr. Thomas Ernandez, Geneva (Speaker) Main points discussed: Early manifestation of sHPT in chronic kidney disease Available therapeutic options and their action on PTH, 25(OH)D, P and Ca (NVD, AVD, Calcimimetics) Extended Release Calcifediol: Advantages and specificities illustrated by clinical studies results THERE IS MORE HERE Specialist information is located in this area. In order to be able to see this, you must verify yourself as a healthcare professional. ?